Medicine and Dentistry
Chemotherapy
100%
Notch
100%
Cutaneous T Cell Lymphoma
100%
Doxorubicin
66%
Gemcitabine
66%
Etoposide
66%
Lymphoma Cell
66%
Small Interfering RNA
33%
Notch Signaling
33%
Upregulation
33%
Psoralen
33%
Messenger RNA
33%
Cell Viability
33%
Genetic Transfection
33%
In Vitro
33%
Cutaneous T-Cell Lymphoma Cell Line
33%
Keyphrases
Cutaneous T-cell Lymphoma
100%
Chemotherapeutic Treatment
100%
Notch1
100%
Lymphoma Cells
42%
Chemotherapy-induced
42%
Gemcitabine
28%
Etoposide
28%
Notch Pathway
28%
Doxorubicin
28%
Cell Viability
14%
Notch Signaling
14%
Protective Mechanism
14%
Notch Targets
14%
Family Members
14%
X-ray
14%
Chemotherapy Alone
14%
Functional Activity
14%
Response to Chemotherapy
14%
Psoralen Plus UVA
14%
Small Interfering RNA (siRNA)
14%
Protein Level
14%
Knockdown
14%
MRNA Level
14%
Immunology and Microbiology
T Cell
100%
Notch
100%
Lymphoma Cell
66%
Cutaneous T-Cell Lymphoma Cell Line
33%
Upregulation
33%
Notch Signaling
33%
X Ray
33%
Genetic Transfection
33%
Cell Viability
33%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Notch
75%
Gemcitabine
50%
Doxorubicin
50%
Notch Signaling Pathway
25%
Cell Viability
25%
Messenger RNA
25%
Small Interfering RNA
25%
Upregulation
25%
Transfection
25%
X Ray
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cutaneous T Cell Lymphoma
100%
Chemotherapy
100%
Gemcitabine
40%
Doxorubicin
40%
Etoposide
40%
Cell Viability
20%
Small Interfering RNA
20%
Messenger RNA
20%
Psoralen
20%